ChromaCode is deploying a disruptive solution for mid-density, multiplexed analysis, high-definition PCR or HDPCR. The technology is comprised of proprietary software and assay design that produces a five-fold increase in a qPCR instrument’s multiplexing capabilities. The technology can be applied for infectious diseases, oncology, personalized medicine, and pharmaceutical research.